News & Updates

New guidelines: Paradigm shift in CV management of T2D patients

27 Sep 2024 by

Recently published cardiovascular outcome trials (CVOTs) in patients with diabetes (DM) have led to updates in the management of cardiovascular disease (CVD) in DM patients. These updates were reflected in the 2019 ESC guidelines on diabetes, prediabetes, and CVD, a collaboration between ESC and EASD*.

New guidelines: Paradigm shift in CV management of T2D patients

27 Sep 2024

Lung function slightly helps lung cancer prediction in nonsmokers

27 Sep 2024

Impaired lung function modestly improves lung cancer prediction in nonsmokers, a recent study has found. In turn, asthma, obesity, air pollution and low birthweight are all associated with worse lung function.

Lung function slightly helps lung cancer prediction in nonsmokers

27 Sep 2024

Complete surgical repair for tetralogy of Fallot ups mortality risk in neonates

25 Sep 2024

Neonates with tetralogy of Fallot who underwent complete surgical repair are at increased risk of early and 2-year mortality compared with those treated with the staged approach, reports a study.

Complete surgical repair for tetralogy of Fallot ups mortality risk in neonates

25 Sep 2024

Physical fitness training not superior to relaxation sessions in patients with subacute stroke

25 Sep 2024 by

An aerobic physical fitness training in adults with moderate-to-severe subacute stroke is not better than relaxation intervention in terms of maximal walking speed and activities of daily living (ADL), a new study has shown. The risk of falls is also higher in participants undergoing physical fitness training.

Physical fitness training not superior to relaxation sessions in patients with subacute stroke

25 Sep 2024

Hypertension and the Asia Pacific region

18 Sep 2024 by

Cardiovascular disease remains one of the leading causes of mortality in the Philippines. Dr. Rafael Castillo, during his presidential lecture delivered at the 10th Asian-Pacific Congress of Hypertension last February 12 to 15 in Cebu City, likened hypertension to a storm surge. Every year, close to 120,000 Filipinos die due to complications related to hypertension. Non-optimal control of blood pressure imposes a huge socioeconomic burden as it causes disruption of work, family and social relationships.

Hypertension and the Asia Pacific region

18 Sep 2024

Hypertension and dementia: is there a link?

18 Sep 2024 by

The age at which one acquires hypertension may matter on the risk of dementia later on, with mid-life hypertension shown to be associated with late-life dementia.

Hypertension and dementia: is there a link?

18 Sep 2024

Dietary management to control hypertension

18 Sep 2024 by

Dietary Approaches to Stop Hypertension (DASH) is a highly effective aspect of the non-pharmacologic management of hypertension. Based on a research sponsored by the US-based National Heart, Lung and Blood Institute, it targets hypertensive as well as normotensive individuals at risk for hypertension.

Dietary management to control hypertension

18 Sep 2024

Incident, proliferative benign breast disease tied to greatest breast cancer risk

17 Sep 2024 by

Women with incident, proliferative benign breast diseases (BBDs) may have an elevated risk of developing breast cancer, according to a retrospective study conducted in Spain.

Incident, proliferative benign breast disease tied to greatest breast cancer risk

17 Sep 2024

ALK+ NSCLC: Real-world patterns and outcomes of treatment after 1L brigatinib

17 Sep 2024 by

Following first-line (1L) brigatinib treatment, most patients with ALK-positive (ALK+) non-small-cell lung cancer (NSCLC) received an ALK tyrosine kinase inhibitor (TKI) as second-line (2L) therapy and experienced prolonged clinical benefit, a retrospective chart review of patients enrolled in the phase III ALTA-1L trial has shown.

ALK+ NSCLC: Real-world patterns and outcomes of treatment after 1L brigatinib

17 Sep 2024

[test headline bait]Amivantamab plus chemo tied to better outcomes in NSCLC

17 Sep 2024 by

Treatment with amivantamab (ami) in combination with chemotherapy (chemo) results in substantially longer time to treatment discontinuation (TTD), time to subsequent therapy (TTST), and progression-free survival (PFS) after first subsequent therapy (PFS2) in patients with EGFR-mutant advanced nonsmall cell lung cancer (NSCLC) following progression on osimertinib, as shown in a postprogression analysis.

[test headline bait]Amivantamab plus chemo tied to better outcomes in NSCLC

17 Sep 2024

News & Updates

Filter by Specialty:

Specialty:

New guidelines: Paradigm shift in CV management of T2D patients

New guidelines: Paradigm shift in CV management of T2D patients

Lung function slightly helps lung cancer prediction in nonsmokers

Lung function slightly helps lung cancer prediction in nonsmokers

Complete surgical repair for tetralogy of Fallot ups mortality risk in neonates

Complete surgical repair for tetralogy of Fallot ups mortality risk in neonates

Physical fitness training not superior to relaxation sessions in patients with subacute stroke

Physical fitness training not superior to relaxation sessions in patients with subacute stroke

Hypertension and the Asia Pacific region

Hypertension and the Asia Pacific region

Hypertension and dementia: is there a link?

Hypertension and dementia: is there a link?

Dietary management to control hypertension

Dietary management to control hypertension

Incident, proliferative benign breast disease tied to greatest breast cancer risk

Incident, proliferative benign breast disease tied to greatest breast cancer risk

ALK+ NSCLC: Real-world patterns and outcomes of treatment after 1L brigatinib

ALK+ NSCLC: Real-world patterns and outcomes of treatment after 1L brigatinib

[test headline bait]Amivantamab plus chemo tied to better outcomes in NSCLC

[test headline bait]Amivantamab plus chemo tied to better outcomes in NSCLC